Nestle launches protein shots for U.S. weight-loss drug users – CTV

Dec. 18, 2024

LONDON – Nestle is launching protein shots in the United States that it says help suppress appetite for people looking to shed pounds, the latest effort by the world’s biggest packaged food maker to tap the booming market for weight-loss products.
The manufacturer of Kit Kat chocolate bars and Nesquik shakes says its drink sparks a natural reaction in the body, which is similar to, but far less powerful than, highly in-demand drugs for weight loss like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound.

The weekly weight-loss injections mimic an intestinal hormone called GLP-1 and curb people’s appetite, promoting a feeling of fullness.

The shake, called Boost Pre-Meal Hunger Support, is to be consumed up to 30 minutes before a meal and is aimed at people taking GLP-1 drugs or other weight-loss medications. The rollout started last month.

“You get an increase in natural GLP-1 which helps in controlling the feeling of hunger. So this dose has a significant effect on satiety,” Stefan Palzer, chief technology officer at Nestle, told Reuters.

Read more: https://www.ctvnews.ca/world/nestle-launches-protein-shots-for-u-s-weight-loss-drug-users-1.7149921